Litcius/Paper detail

Reassembling of albumin-bound paclitaxel mitigates myelosuppression and improves its antitumoral efficacy via neutrophil-mediated targeting drug delivery

Yuxin Chen, Lulu Han, Xiaoyan Qiu, Meng Wang, Zheng Chen, Ying Cai, Yong Xin, Yan-Fang Lv, Ankang Hu, Dafei Chai, Liantao Li, Huizhong Li, Junnian Zheng, Gang Wang

2022Drug Delivery22 citationsDOIOpen Access PDF

Abstract

but do not affect neutrophils' function, such as chemotaxis and activation. In a murine tumor model, we further proved that local radiotherapy (RT) induced inflammation activated peripheral neutrophils to capture venous infused NP-abPTX and carry them into tumor tissue. As compared to abPTX, infusion of NP-abPTX dramatically enhanced inhibition of tumor growth treated by local RT and mitigated hematotoxicity. Therefore, our study demonstrated a novel strategy to mitigate side-effects and to improve tumor killing efficacy of abPTX through neutrophil-mediated targeting drug delivery.

Topics & Concepts

PaclitaxelIn vivoPharmacologyDrug deliveryAlbuminDrugMedicineIn vitroCancer researchChemotaxisChemotherapyImmunologyChemistryBiologyInternal medicineReceptorBiochemistryOrganic chemistryBiotechnologyNanoplatforms for cancer theranosticsInflammatory Biomarkers in Disease PrognosisImmune cells in cancer